tirzepatide group outperformed semaglutide weight-loss drug results in real world patients, study shows New Dual Incretin Agonist for

Retatrutide and Tirzepatide: Retatrutide and Tirzepatide are newer additions to the GLP-1 analogue family and are currently under investigation in clinical trials for obesity treatment

Once eligibility is verified by a third-party partner, patients are connected directly to licensed clinicians, creating a clear, fast path into care

Additionally, it exerts a highly favourable effect on diabetes prevention in individuals with prediabetes (HR: 0.07 compared to placebo)41 (Table 1)

Last year, the team published a paper with further analysis of the data

Semaglutide Alleviated Systemic and Ovarian Inflammation As shown in Figure 4A, immunohistochemical staining was used to determine the effect of semaglutide on ovarian tissue inflammation

This finding suggests a direct correlation between the analgesic effects of GLP-1R signaling and its Anti-neuroinflammatory activity